BIOMAT Database Logo BIOMAT Database Logo

Resistance to murine acquired immunodeficiency syndrome (MAIDS) 1994

R A Morawetz, and T M Doherty, and N A Giese, and J W Hartley, and W Müller, and R Kühn, and K Rajewsky, and R Coffman, and H C Morse

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D008817 Mice, Mutant Strains Mice bearing mutant genes which are phenotypically expressed in the animals. Mouse, Mutant Strain,Mutant Mouse Strain,Mutant Strain of Mouse,Mutant Strains of Mice,Mice Mutant Strain,Mice Mutant Strains,Mouse Mutant Strain,Mouse Mutant Strains,Mouse Strain, Mutant,Mouse Strains, Mutant,Mutant Mouse Strains,Mutant Strain Mouse,Mutant Strains Mice,Strain Mouse, Mutant,Strain, Mutant Mouse,Strains Mice, Mutant,Strains, Mutant Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D004198 Disease Susceptibility A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases. Diathesis,Susceptibility, Disease,Diatheses,Disease Susceptibilities,Susceptibilities, Disease
D006377 T-Lymphocytes, Helper-Inducer Subpopulation of CD4+ lymphocytes that cooperate with other lymphocytes (either T or B) to initiate a variety of immune functions. For example, helper-inducer T-cells cooperate with B-cells to produce antibodies to thymus-dependent antigens and with other subpopulations of T-cells to initiate a variety of cell-mediated immune functions. Helper Cell,Helper Cells,Helper T Cell,Helper-Inducer T-Lymphocytes,Inducer Cell,Inducer Cells,T-Cells, Helper-Inducer,T-Lymphocytes, Helper,T-Lymphocytes, Inducer,Helper T-Cells,Cell, Helper T,Cells, Helper T,Helper Inducer T Lymphocytes,Helper T Cells,Helper T-Cell,Helper T-Lymphocyte,Helper T-Lymphocytes,Helper-Inducer T-Cell,Helper-Inducer T-Cells,Helper-Inducer T-Lymphocyte,Inducer T-Lymphocyte,Inducer T-Lymphocytes,T Cell, Helper,T Cells, Helper,T Cells, Helper Inducer,T Lymphocytes, Helper,T Lymphocytes, Helper Inducer,T Lymphocytes, Inducer,T-Cell, Helper,T-Cell, Helper-Inducer,T-Cells, Helper,T-Lymphocyte, Helper,T-Lymphocyte, Helper-Inducer,T-Lymphocyte, Inducer
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015847 Interleukin-4 A soluble factor produced by activated T-LYMPHOCYTES that induces the expression of MHC CLASS II GENES and FC RECEPTORS on B-LYMPHOCYTES and causes their proliferation and differentiation. It also acts on T-lymphocytes, MAST CELLS, and several other hematopoietic lineage cells. B-Cell Growth Factor-I,B-Cell Stimulatory Factor-1,Binetrakin,IL-4,Mast Cell Growth Factor-2,B Cell Stimulatory Factor-1,B-Cell Growth Factor-1,B-Cell Proliferating Factor,B-Cell Stimulating Factor-1,B-Cell Stimulatory Factor 1,BCGF-1,BSF-1,IL4,MCGF-2,B Cell Growth Factor 1,B Cell Growth Factor I,B Cell Proliferating Factor,B Cell Stimulating Factor 1,B Cell Stimulatory Factor 1,Interleukin 4,Mast Cell Growth Factor 2
D016183 Murine Acquired Immunodeficiency Syndrome Acquired defect of cellular immunity that occurs in mice infected with mouse leukemia viruses (MuLV). The syndrome shows striking similarities with human AIDS and is characterized by lymphadenopathy, profound immunosuppression, enhanced susceptibility to opportunistic infections, and B-cell lymphomas. AIDS, Murine,MAIDS,Murine AIDS,Murine Acquired Immune Deficiency Syndrome,Murine Acquired Immuno-Deficiency Syndrome,AIDSs, Murine,Murine AIDSs,Murine Acquired Immuno Deficiency Syndrome
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine

Related Publications

R A Morawetz, and T M Doherty, and N A Giese, and J W Hartley, and W Müller, and R Kühn, and K Rajewsky, and R Coffman, and H C Morse
Resistance to murine acquired immunodeficiency syndrome (MAIDS)
July 1994, Science (New York, N.Y.),
R A Morawetz, and T M Doherty, and N A Giese, and J W Hartley, and W Müller, and R Kühn, and K Rajewsky, and R Coffman, and H C Morse
Thymus involvement in murine acquired immunodeficiency (MAIDS).
January 1994, Thymus,
R A Morawetz, and T M Doherty, and N A Giese, and J W Hartley, and W Müller, and R Kühn, and K Rajewsky, and R Coffman, and H C Morse
Destruction of follicular dendritic cells in murine acquired immunodeficiency syndrome (MAIDS).
January 1993, Advances in experimental medicine and biology,
R A Morawetz, and T M Doherty, and N A Giese, and J W Hartley, and W Müller, and R Kühn, and K Rajewsky, and R Coffman, and H C Morse
Murine acquired immunodeficiency syndrome (MAIDS): an animal model to study the AIDS pathogenesis.
July 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
R A Morawetz, and T M Doherty, and N A Giese, and J W Hartley, and W Müller, and R Kühn, and K Rajewsky, and R Coffman, and H C Morse
Morphological changes of thymus in retrovirus-induced murine acquired immunodeficiency syndrome (MAIDS).
July 1995, Pathology, research and practice,
R A Morawetz, and T M Doherty, and N A Giese, and J W Hartley, and W Müller, and R Kühn, and K Rajewsky, and R Coffman, and H C Morse
Kinetics of ex-vivo cytokine production by splenocytes during murine acquired immunodeficiency syndrome (MAIDS).
January 1995, European cytokine network,
R A Morawetz, and T M Doherty, and N A Giese, and J W Hartley, and W Müller, and R Kühn, and K Rajewsky, and R Coffman, and H C Morse
Does preferential Th subset activation contribute to the murine acquired immunodeficiency disease (MAIDS)?
January 1994, Research in immunology,
R A Morawetz, and T M Doherty, and N A Giese, and J W Hartley, and W Müller, and R Kühn, and K Rajewsky, and R Coffman, and H C Morse
Induction of murine acquired immunodeficiency syndrome (MAIDS) in allophenic mice generated from strains susceptible and resistant to disease.
December 1996, The Journal of experimental medicine,
R A Morawetz, and T M Doherty, and N A Giese, and J W Hartley, and W Müller, and R Kühn, and K Rajewsky, and R Coffman, and H C Morse
Increased Fas antigen expression in murine retrovirus-induced immunodeficiency syndrome, MAIDS.
October 1994, European journal of immunology,
R A Morawetz, and T M Doherty, and N A Giese, and J W Hartley, and W Müller, and R Kühn, and K Rajewsky, and R Coffman, and H C Morse
In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS).
December 1994, The Journal of experimental medicine,
Copied contents to your clipboard!